Nachrichten zur AstraZeneca PLC Aktie

AstraZeneca started at outperform with $82 stock price target at BMO Capital

Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…

Sanofi, AstraZeneca Respiratory Treatment Nirsevimab Biologics License Accepted by FDA

Sanofi, AstraZeneca Respiratory Treatment Nirsevimab Biologics License Accepted by FDA...…

Form 6-K ASTRAZENECA PLC For: Jan 03

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Total Voting Rights

3 January 2023 15:00 GMT Transparency Directive Voting rights and capital The following notification is made in accordance with the UK Financial Conduct…

GSK Looking For Under-Appreciated M&A Targets, Not Trying To Be Next Roche Or AstraZeneca

GSK plc (NYSE: GSK) chief commercial officer Luke Miels says the company is looking at M&A targets that are under-appreciated worth…

Global Bronchitis Treatments (Acute, Chronic) Market Report 2022-2027 Featuring Leading Players - AstraZeneca, Bayer, Cipla, Sanofi and Pfizer

DUBLIN, Dec. 30, 2022 /PRNewswire/ -- The "Bronchitis Treatments: Global Markets" report has been added to ResearchAndMarkets.coms offering. This study…

Form 6-K ASTRAZENECA PLC For: Dec 30

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

ADRs End Mostly Lower, AstraZeneca and ABB Trade Actively

ADRs End Mostly Lower, AstraZeneca and ABB Trade Actively...…

Form 6-K ASTRAZENECA PLC For: Dec 28

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

AstraZeneca Cancer Drug Gets First Japan Nod as Approvals Grow

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

TOP NEWS: AstraZeneca wins approvals for cancer treatments in Japan

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

LONDON BRIEFING: UK strikes continue; AstraZeneca wins Japan approvals

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

AstraZeneca: Imfinzi + Imjudo Approved In Japan For Advanced Liver, Biliary Tract And Lung Cancers

LONDON (dpa-AFX) - British drug major AstraZeneca Plc. (AZN.L, AZN) announced Wednesday that its immunotherapies Imfinzi (durvalumab) and Imjudo (tremelimumab)…

Calquence Japan approval for treatment-naïve CLL

28 December 2022 07:05 GMT Calquence approved in Japan for adults with treatment-naïve chronic lymphocytic leukaemia Calquence significantly increased the time patients lived without…

The Zacks Analyst Blog Highlights Novo Nordisk, AstraZeneca, Accenture, Chubb and Roper Technologies

Novo Nordisk, AstraZeneca, Accenture, Chubb and Roper Technologies are part of the Zacks top Analyst Blog....…

Top Research Reports for Novo Nordisk, AstraZeneca & Accenture

Todays Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), AstraZeneca PLC (AZN) and…

ADRs End Higher, AstraZeneca and Carnival Trade Actively

ADRs End Higher, AstraZeneca and Carnival Trade Actively...…

AstraZeneca (AZN) Gets EU Nod to Expanded Use of 2 Cancer Drugs

The European Commission approves AstraZenecas (AZN) two key cancer drugs Lynparza and Imfinzi for expanded use....…

AstraZeneca has two of its cancer drugs approved for use in the EU

The FTSE 100 pharma giant said Imfinzi has been given the green light in the EU for the treatment of…

Form 6-K ASTRAZENECA PLC For: Dec 21

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

AstraZeneca wins two new approvals in EU for cancer drugs

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

AstraZeneca Imfinzi combo for biliary tract cancer gets approval in EU

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

AstraZeneca: Imfinzi Combination Approved In EU For Advanced Biliary Tract Cancer Treatment

LONDON (dpa-AFX) - British drug major AstraZeneca Plc.s (AZN.L, AZN) Imfinzi (durvalumab) has been approved in the European Union for…

AstraZeneca: Lynparza In Combination With Abiraterone Approved In EU For Prostate Cancer

LONDON (dpa-AFX) - AstraZeneca (AZN, AZN.L), on Wednesday, announced that Lynparza (olaparib) in combination with abiraterone and prednisone or prednisolone…

AstraZenca, G42 Healthcare enter strategic partnership to manufacture pharmaceutical products in Abu Dhabi

ABU DHABI, UAE, Dec. 20, 2022 /PRNewswire/ -- Building on the ongoing efforts of the Department of Health – Abu…

Astrazeneca (AZN) Stock Moves -0.69%: What You Should Know

Astrazeneca (AZN) closed the most recent trading day at $67.47, moving -0.69% from the previous trading session....…

ADRs End Mixed; AstraZeneca, atai Life Sciences Trade Actively

ADRs End Mixed; AstraZeneca, atai Life Sciences Trade Actively...…

AstraZeneca posts mixed results from lung cancer trial

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 6-K ASTRAZENECA PLC For: Dec 19

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

AstraZeneca Drug Imfinzi Fails As Monotherapy In Metastatic Lung Cancer Setting

read more...…

TOP NEWS: AstraZeneca receives host of EU approvals or recommendations

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

AstraZeneca: Enhertu Gets CHMP Recommendation For EU Approval For HER2-low Metastatic Breast Cancer

LONDON (dpa-AFX) - British drug major AstraZeneca Plc (AZN.L, AZN) announced Monday that the European Medicines Agencys Committee for Medicinal…

AstraZeneca Says Enhertu Approved In EU To Treat Advanced HER2-positive Gastric Cancer.

LONDON (dpa-AFX) - AstraZeneca (AZN.L) on Monday said Enhertu, jointly developed by AstraZeneca and Daiichi Sankyo, has been approved in…

AstraZeneca: CHMP Recommends Imfinzi And Imjudo Combinations For Advanced Liver And Lung Cancers

LONDON (dpa-AFX) - AstraZeneca (AZN.L, AZN) said the Committee for Medicinal Products for Human Use of the European Medicines Agency…

UPDATE 1-AstraZeneca drug Imfinzi fails as monotherapy for type of lung cancer

...(Adds details, background) Dec 19 (Reuters) - AstraZeneca said......…

EU-Zulassungsempfehlung für Astrazeneca-Kombination Imfinzi-Imjudo

Von Anthony O. Goriainoff LONDON (Dow Jones)--Der Pharmakonzern Astrazeneca hat für eine Kombinationstherapie seiner Krebsmittel Imfinzi und Imjudo eine…

FTSE News: Joules Shares Canceled, AstraZeneca Trial Results ...

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

AstraZeneca says Imfinzi fails as monotherapy for type of lung cancer

...Dec 19 (Reuters) - AstraZeneca said on Monday its drug Imfinzi failed......…

AstraZeneca: Imfinzi Fails To Meet Statistical Significance For Primary Goals In PEARL Trial

LONDON (dpa-AFX) - British drug major AstraZeneca Plc (AZN.L, AZN) announced Monday that Imfinzi (durvalumab) did not achieve statistical significance…

AstraZeneca: CHMP Recommends Forxiga For Approval In Adults For Treatment Of Symptomatic Chronic HF

LONDON (dpa-AFX) - AstraZeneca (AZN.L, AZN) said its Forxiga has been recommended for approval in the European Union to extend…

Astrazeneca erhält EU-Zulassungempfehlung für Herzmittel Forxiga

Von Anthony O. Goriainoff LONDON (Dow Jones)--Der Pharmakonzern Astrazeneca hat für sein Medikament Forxiga in der EU eine Zulassungsempfehlung…

Update on Imfinzi PEARL trial

19 December 2022 07:05 GMT Update on PEARL Phase III trial of Imfinzi monotherapy in Stage IV non-small cell lung cancer The PEARL Phase III…

Implied Volatility Surging for AstraZeneca (AZN) Stock Options

Investors need to pay close attention to AstraZeneca (AZN) stock based on the movements in the options market lately....…

Merck, AstraZeneca Receive FDA Extension on Lynparza New Drug Application Date

Merck, AstraZeneca Receive FDA Extension on Lynparza New Drug Application Date...…

Form 6-K ASTRAZENECA PLC For: Dec 15

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Zacks Industry Outlook Highlights Johnson & Johnson, Novo Nordisk, Merck and AstraZeneca

Johnson & Johnson, Novo Nordisk, Merck and AstraZeneca have been highlighted in this Industry Outlook article....…

AstraZeneca and Merck receive US FDA extension for Lynparza review

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

AstraZeneca: FDA To Extend PDUFA Date Regarding SNDA For Lynparza With Abiraterone

LONDON (dpa-AFX) - AstraZeneca (AZN.L, AZN) and MSD announced the FDA has informed AstraZeneca that it will extend the PDUFA…

Update on US review of Lynparza PROpel sNDA

15 December 2022 07:00 GMT Update on US regulatory priority review of Lynparza in combination with abiraterone in metastatic castration-resistant prostate cancer AstraZeneca and MSD today…

Astrazeneca (AZN) is a Top-Ranked Value Stock: Should You Buy?

Whether youre a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top…